Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Prevalence of chronic kidney disease (CKD) in people with diagnosed diabetes is known to be high, but little is known about the prevalence of CKD in those with undiagnosed diabetes or prediabetes. We aimed to estimate and compare the community prevalence of CKD among people with diagnosed diabetes, undiagnosed diabetes, prediabetes, or no diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The 1999 through 2006 National Health and Nutrition Examination Survey is a representative survey of the civilian, noninstitutionalized US population. Participants who were aged > or =20 years; responded to the diabetes questionnaire; and had fasting plasma glucose (FPG), serum creatinine, and urinary albumin-creatinine ratio measurements were included (N = 8188). Diabetes status was defined as follows: Diagnosed diabetes, self-reported provider diagnosis (n = 826); undiagnosed diabetes, FPG > or =126 mg/dl without self-reported diagnosis (n = 299); prediabetes, FPG > or =100 and <126 mg/dl (n = 2272); and no diabetes, FPG <100 mg/dl (n = 4791). Prevalence of CKD was defined by estimated GFR 15 to 59 ml/min per 1.73 m(2) or albumin-creatinine ratio > or =30 mg/g; adjustment was performed with multivariable logistic regression. RESULTS: Fully 39.6% of people with diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with prediabetes and 10.6% without diabetes had CKD. Age-, gender-, and race/ethnicity-adjusted prevalence of CKD was 32.9, 24.2, 17.1, and 11.8%, for diagnosed, undiagnosed, pre-, and no diabetes, respectively. Among those with CKD, 39.1% had undiagnosed or prediabetes. CONCLUSIONS: CKD prevalence is high among people with undiagnosed diabetes and prediabetes. These individuals might benefit from interventions aimed at preventing development and/or progression of both CKD and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, evidence of a cross-sectional association between prediabetes and eGFR, a late marker of CKD, is mixed, including both studies with positive54 and null findings.55,57”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“The NHANES 1999–2006 showed increasing frequency of albuminuria in tandem with the glycaemia range when classified from normoglycaemia through IFG, undiagnosed diabetes and diagnosed diabetes for both microalbuminuria, which may also relate to hypertension and is therefore an imprecise marker of diabetes-related early nephropathy (6%, 10%, 29% and 29%, respectively) and macroalbuminuria (0.6%, 1.1”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
In the citing paper
“There is evidence to link prediabetes to increased risk of early forms of nephropathy and chronic kidney disease (CKD), defined based on methods such as urinary albumin excretion rate (AER) and estimated glomerular filtration rate (eGFR).51–55”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725 · cited 9×
“The unadjusted CKD prevalence using the MDRD Study equation (7) was 39.6 and 41.7% in those with diagnosed and undiagnosed diabetes, respectively (Figure 1A).”
MethodInfluentialSelf-citationBasevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154
Self-citationChronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Self-citationKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 1×
“We defined CKD as either reduced kidney function or elevated albuminuria, because reduced kidney function may occur even in the absence of albuminuria in those with type 2 diabetes (5,6).”
BackgroundImprovements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Research works printed but not linked: 3
- US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009 [Google Scholar]
- Centers for Disease Control and Prevention: National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007, Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed February 1, 2009 [Google Scholar]
- Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159–2167, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Items 401–421 of 421
Jadhakhan, F., Safi, A., Gai, B., Hossain, M. Z., & AlKhatib, A. H. (2025) · European Medical Journal · doi:10.33590/emj/baok8956
Cao, M., Wu, G., Zhang, M., Chang, Y., Guo, W., Zhao, S., & Zhang, L. (2025) · Appetite · doi:10.1016/j.appet.2025.108435
Chen, H.-W., Liu, K., Cao, B., Zhong, Q., Zhou, R., Li, L.-H., Wang, S.-A., Wei, Y.-F., Liu, H.-M., & Wu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26733220
Wen, J., Wang, A., Liu, G., Wang, M., Zuo, Y., Li, W., Zhai, Q., Mu, Y., Gaisano, H. Y., He, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13100922
Mai, A. (2019) · Qucosa (Saxon State and University Library Dresden)
Saydam, H. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-48510
START Diabetes Prevention: A Multilevel Strategy for Primary Care Clinics
Tseng, E., Marsteller, J. A., Clark, J. M., & Maruthur, N. M. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0054
Protéinuries génétiques causées par déficit de réabsorption tubulaire proximale
Bedin, M. (2019) · theses.fr (ABES) · doi:10.70675/a3dc7a92z6158z43fez9b6bzb9ad00e7acbf
The effect of obesity and diabetes in the end stage renal disease (ESRD) cohort
Kakar, A. (2021) · theses.fr (ABES) · doi:10.70675/e7c688d8z8b15z45adz9978z76af27506fd6
Akar, E. A. (2022) · theses.fr (ABES) · doi:10.70675/a7b15e3fz84e7z4915z9447zc112181e06e4
Cheuy, V. A., Sadoughi, S., Moon, H., Ellis, J., Gross, R., Sinacore, D. R., Hastings, M. K., Souza, R. B., & Kazakia, G. J. (2026) · JBMR Plus · doi:10.1093/jbmrpl/ziag058
Zhang, Y., Chan, C. H., Lam, H., Bishai, D. M., Clarke, P., Tang, S. C. W., & Quan, J. (2026) · BMC Nephrology · doi:10.1186/s12882-026-04991-1
From static lipids to dynamic risk: The role of atherogenic index of plasma in prediabetes
Berthold, H. K., Gouni‐Berthold, I., & Rizzo, M. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109346
Patel, D., Kramer, H. J., Silva, A., Qeadan, F., & Markossian, T. W. (2026) · BMC Nephrology · doi:10.1186/s12882-026-05086-7
Zoller, A. R., Athinarayanan, S. J., Tieghem, M. R. V., Adams, R. N., Roberts, C. G. P., Volek, J. S., Phinney, S. D., & McKenzie, A. L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1839029
Association between prediabetes and nephropathy: a comprehensive systematic review and meta-analysis
Karimi, R., Riahi, R., Mortazavi, M., Sindarreh, S., Aminorroaya, A., & Maracy, M. R. (2026) · BMC Nephrology · doi:10.1186/s12882-026-05212-5
Chen, B., Alexopoulos, A., Lau, W. C., Thakoor, K. A., Lee, C. S., Metwally, A. A., & Dunn, J. (2026) · medRxiv · doi:10.64898/2026.08.14.26360480
Noor, S. K., Ali, H. S. A. H. M., Eldouma, M. Y. M., Mansour, W. A. M. A., Abdelgadir, E., Almaryoud, E. Z. A., Samel, M. Y. A. A. M., Mohammed, A. M. A., Omara, W. A., Dawla, S. G. E., et al. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-004767
Leong, W. B. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Metadata
- Authors
- Plantinga, L. C., Crews, D. C., Coresh, J., Miller, E. R., Saran, R., Yee, J., Hedgeman, E., Pavkov, M., Eberhardt, M. S., Williams, D. E., & Powe, N. R.
- Affiliations
- San Francisco General Hospital (US)
- Johns Hopkins University (US)
- University of Michigan (US)
- Henry Ford Health (US)
- Centers for Disease Control and Prevention (US)
- University of California, San Francisco (US)
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2010-04
- Volume
- 5
- Issue
- 4
- Pages
- 673-682
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2849697
- OpenAlex
- W2128714303
- Cited by
- 408
- References
- 28
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 24 · 2023: 25 · 2022: 18 · 2021: 30 · 2020: 28 · 2019: 29 · 2018: 32 · 2017: 26 · 2016: 34 · 2015: 31 · 2014: 27 · 2013: 28 · 2012: 15
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK02643, K24DK002643)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- chronic kidney disease, undiagnosed diabetes, prediabetes, diabetes prevalence, albumin-creatinine ratio, estimated glomerular filtration rate, NHANES, diabetes screening
- MeSH terms
- Adult, Albuminuria, Blood Glucose, Chronic Disease, Creatinine, Diabetes Mellitus, Fasting, Female, Glomerular Filtration Rate, Health Surveys, Humans, Kidney Diseases, Male, Mass Screening, Middle Aged, Prediabetic State, Predictive Value of Tests, Surveys and Questionnaires, United States, Biomarkers, Comorbidity, Prevalence, Chi-Square Distribution, Logistic Models, Early Diagnosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.